Exclusive: GSK nears deal to buy Human Genome - sources
19:08 EDT 15 Jul 2012 | Reuters
NEW YORK/LONDON (Reuters) - GlaxoSmithKline is nearing a deal to acquire Human Genome Sciences for about $2.8 billion in cash after pursuing the U.S. biotech company for three months, two sources familiar with the situation said on Sunday.
Original Article: Exclusive: GSK nears deal to buy Human Genome - sources
More From BioPortfolio on "Exclusive: GSK nears deal to buy Human Genome - sources"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
